Research Disclosures & Disclaimers

This website contains disclosures and disclaimers related to
published UBS Global Research products, including those related to
regulation, potential conflicts of interest as well as those provided
by third-party data providers describing limitations on use of their
products.

DocMorris (DOCM.S)*

UBS Rating and Price Target History Chart

Line chart explaining Price target vs Stock Price is described in below table

EQ Rating & Price Target Table

Date	Stock Price (CHF)	Price Target (CHF)	Rating
2022-02-25	78.79	83.217	Sell
2022-03-29	61.75	46.779	Sell
2022-06-08	50.72	45.794	Sell
2022-08-03	35.65	27.575	Sell
2022-10-12	12.31	11.572	Sell
2023-02-07	25.70	21.174	Sell
2023-06-09	14.87	13.295	Sell
2023-08-24	32.01	14.526	Sell
2023-10-20	18.18	14.28	Sell
2024-04-02	42.84	15.708	Sell
2024-06-04	30.65	14.28	Sell
2024-08-21	20.68	13.295	Sell
2024-10-17	15.50	12.31	Sell
2025-02-07	9.26	8.00	Sell
2025-03-13	7.42	-	No Rating

Disclosures

UBS AG is acting as manager/co-manager, underwriter, placement or sales agent in regard to an offering of securities of this company/entity or one of its affiliates.
Within the past 12 months, UBS has received compensation for investment banking services from this company/entity or one of its affiliates.
UBS expects to receive or intend to seek compensation for investment banking services from this company/entity within the next three months.
Because this security exhibits higher-than-average volatility, the FSR has been set at 15% above the MRA for a Buy rating, and at -15% below the MRA for a Sell rating (compared with 6/-6% under the normal rating system).
UBS holds a long or short position of 0.5% or more of the listed shares of this company.
UBS Fund Management (Switzerland) AG beneficially owns more than 5% of the total issued share capital of this company.
UBS Group AG, its affiliates or subsidiaries beneficially own more than 25% of the total issued share capital of this company.

Note : Historical Price Targets have been adjusted to account for any stock splits, rights issues and/or dividends which may have occurred for this security. Not Priced: Stock was not priced on the given date. No Rating: Issuer was not rated by UBS on the given day. No Price Target: For this issuer no Price Target was set by UBS on the given day. Issuers with an EQ Rating & Price Target Table are covered by UBS-IB Equity Research Analysts. Issuers without an EQ Rating & Price Target Table are not single stock covered.

* Issuers marked with an asterisk are covered by UBS-IB Equity Research Analysts. Issuers without an asterisk are not single stock covered.